| 000 | 01730 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515043422.0 | ||
| 264 | 0 | _c20061026 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a0025-6196 | ||
| 024 | 7 |
_a10.4065/81.10.1321 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFife, Kenneth H | |
| 245 | 0 | 0 |
_aEffect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial. _h[electronic resource] |
| 260 |
_bMayo Clinic proceedings _cOct 2006 |
||
| 300 |
_a1321-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcyclovir _xadverse effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHerpes Genitalis _xdrug therapy |
| 650 | 0 | 4 |
_aHerpesvirus 2, Human _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 |
_aProdrugs _xadverse effects |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aValacyclovir |
| 650 | 0 | 4 |
_aValine _xadverse effects |
| 650 | 0 | 4 |
_aVirus Shedding _xdrug effects |
| 700 | 1 | _aWarren, Terri J | |
| 700 | 1 | _aFerrera, R David | |
| 700 | 1 | _aYoung, Douglas G | |
| 700 | 1 | _aJustus, Scott E | |
| 700 | 1 | _aHeitman, Catherine K | |
| 700 | 1 | _aBurroughs, Scott M | |
| 773 | 0 |
_tMayo Clinic proceedings _gvol. 81 _gno. 10 _gp. 1321-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4065/81.10.1321 _zAvailable from publisher's website |
| 999 |
_c16612822 _d16612822 |
||